Age-related Macular Degeneration

1. Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.- 2. Ocular Imaging for Enhancing the Understanding, Assessment, and Management of Age-Related Macular Degeneration.- 3. Histopathology of Age-Related Macular Degeneration and Implications for Pathogenesis and Therapy.- 4. Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.- 5. Innate Immunity in Age-Related Macular Degeneration.- 6. Immunological Aspects of Age-Related Macular Degeneration.- 7. AMD Genetics: Methods and Analyses for Association, Progression, and Prediction.- 8. Making Biological Sense of Genetic Studies of Age-Related Macular Degeneration.- Age-Related Macular Degeneration: From Epigenetics to Therapeutic Implications.- 10. Mitochondria: The Retina's Achilles' Heel in AMD.- 11. Cell-Based Therapies for Age-Related MacularDegeneration.- 12. Current Management of Age-Related Macular Degeneration.

Emily Y. Chew is the Director of the Division of Epidemiology and Clinical Applications (DECA), at the National Eye Institute, the National Institutes of Health in Bethesda, Maryland. She is also the Chief of the Clinical Trials Branch. Emily received her medical degree and her ophthalmology training at the U. of Toronto, School of Medicine, in Toronto, Canada. She completed her fellowship in Medical Retina at the Wilmer Eye Institute, the Johns Hopkins Medical Institutes and the U. of Nijmegen, the Netherlands.  Her research interest includes designing and conducting phase I/II;III clinical trials and epidemiologic studies in chronic retinovascular diseases such as age-related macular degeneration, diabetic retinopathy, the leading causes of blindness in the US.  She was actively involved with leadership roles in the conduct of clinical trials such as Age-Related Eye Disease Study, the Age-Related Eye Disease Study 2, the Actions to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, the Macular Telangiectasia Project (Mac Tel Project) with phase 1 to 3 clinical trials using ciliary neurotrophic factor (CNTF). She chairs the current international study, known as the AMD Ryan Initiative Study (ARIS), which evaluates the natural course of early AMD. She also collaborates with colleagues at the National Library of Medicine (NLM/NIH) utilizing of artificial intelligence/deep learning on the detection and progression of age-related macular degeneration.



Emily Chew has been recognized for her scientific accomplishments, and mentoring efforts by the National Institutes of Health and numerous professional societies in the area of retinal research.


Dr. Anand Swaroop obtained his Ph.D. in Biochemistry at the Indian Institute of Science, Bangalore, India.  After his postdoctoral training at Yale University, he joined the faculty at the University of Michigan in the Departments of Ophthalmology and